“The stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
“This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures,” says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video.
https://www.youtube.com/watch?v=QK7JquljkBc.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network’s Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: “Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting.”
Dr. Dick explains: “When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
The Latest Google Headlines on: Colon cancer
[google_news title=”” keyword=”Colon cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Colon cancer
- Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Recordson April 26, 2024 at 12:51 pm
Integrating AI into electronic messaging systems may help relieve physician burden and improve patient education but still requires a "physician in the loop" as a backstop for errors in messaging. ( ...
- Colorectal cancer rates have increased in those under 55on April 25, 2024 at 8:24 am
The rates of colon and rectal cancer in people under 55 continue to rise. Now millennials get colon cancer twice as much as other adults, and rectal cancer four times as much.
- Symptoms That May Signal Early Colon Canceron April 25, 2024 at 6:31 am
Diagnosing colon cancer early is important so that it can be treated most effectively. Paying attention to any possible symptoms is key. While there may be symptoms of early colon cancer, sometimes ...
- Ask the doctors: Study lookks at role of oral microbe in colorectal canceron April 25, 2024 at 6:06 am
Dear Doctors: I recently read about a study that found a link between a certain kind of bacteria that lives in your mouth and the risk of developing colon cancer. I would like to know more details ...
- Young adults at highest risk of being diagnosed with colorectal canceron April 24, 2024 at 1:44 pm
Getting better sleep, exercising, diversifying your microbiome and getting regular screenings can help reduce the risks of colorectal cancer.
- ‘Wasn’t normal’: Colorectal cancer rates rising among young adultson April 24, 2024 at 1:29 pm
John Johnson of Westlake was the epitome of health, eating the right foods and staying active, completing the 2023 Cleveland marathon in less than three hours.
- Aspirin boosts immune response against colon cancer, study showson April 24, 2024 at 7:02 am
Tissue samples from aspirin users showed less cancer spread to the lymph nodes, and more aggressive activity of immune cells against tumors, the researchers said. In the lab, they discovered that ...
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- Researchers developing new colon cancer tests amid rising caseson April 23, 2024 at 3:01 am
With more than 200,000 cases of colon cancer diagnosed across the country every year, researchers are working on new ways to detect the disease better.
- Mom and Daughter Diagnosed with Colon Cancer 10 Days Apart: ‘What on Earth Would Be the Chances?’on April 22, 2024 at 10:46 am
Rhiannon Tudor and her mom, Catherine, were diagnosed with colon cancer within the same two week period. While Catherine is now cancer-free, Rihannon’s health struggle still continues.
The Latest Google Headlines on: Therapeutic stem cells
[google_news title=”” keyword=”therapeutic stem cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on: Therapeutic stem cells
- Celebrities Quietly Paying Huge Amounts for Anti-Aging Stem Cell Therapy That May Cause Gruesome Side Effectson April 27, 2024 at 6:31 am
Experts caution that there's limited evidence backing the benefits of these stem cell treatments, while pointing to plenty of risks.
- New prototype that regenerates stem cells may repair IPF scarringon April 26, 2024 at 10:42 am
Researchers developed NZ-97, an inhalable drug that stimulates the growth of stem cells in the lungs, potentially repairing scarring in IPF.
- Secret to eternal youth? John Cleese extols virtues of stem cell treatmenton April 26, 2024 at 9:12 am
Therapy has remarkable medical potential but experts say private clinics making far-reaching claims operate in regulatory grey zone ...
- CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumorson April 25, 2024 at 11:30 pm
For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell ...
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseon April 25, 2024 at 6:00 am
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- New device improves stem cell generation and chance for accessible Alzheimer's cell therapyon April 24, 2024 at 12:11 pm
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance that they say helps close the gap for accessible personalized cell-based ...
- The murky, unregulated world of anti-ageing stem cell therapyon April 24, 2024 at 10:50 am
Stem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly spending tens of thousands of pounds each year on expensive therapies offered by private longevity clinics ...
- LSU researchers develop syringe device for enhanced stem cell therapyon April 24, 2024 at 6:00 am
LSU researchers led by veterinary medicine professor Mandi Lopez have introduced a groundbreaking syringe device that could revolutionize tendon injury treatment.
- Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidateson April 24, 2024 at 4:25 am
Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is ...
- John Cleese says he’s been spending £17,000 annually on stem cell therapy to ‘buy a few extra years’on April 24, 2024 at 1:01 am
John Cleese has revealed he has been spending £17,000 every 12 months for the past 20 years on stem cell therapy in an attempt to combat the effects of ageing. The Monty Python star and co-creator, ...
